351 related articles for article (PubMed ID: 26648515)
1. Sendai virus as a backbone for vaccines against RSV and other human paramyxoviruses.
Russell CJ; Hurwitz JL
Expert Rev Vaccines; 2016; 15(2):189-200. PubMed ID: 26648515
[TBL] [Abstract][Full Text] [Related]
2. Development of recombinant Sendai virus vaccines for prevention of human parainfluenza and respiratory syncytial virus infections.
Hurwitz JL
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S126-8. PubMed ID: 18820573
[TBL] [Abstract][Full Text] [Related]
3. Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.
Mackow N; Amaro-Carambot E; Liang B; Surman S; Lingemann M; Yang L; Collins PL; Munir S
J Virol; 2015 Oct; 89(20):10319-32. PubMed ID: 26223633
[TBL] [Abstract][Full Text] [Related]
4. Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections.
Zhan X; Slobod KS; Krishnamurthy S; Luque LE; Takimoto T; Jones B; Surman S; Russell CJ; Portner A; Hurwitz JL
Vaccine; 2008 Jun; 26(27-28):3480-8. PubMed ID: 18499307
[TBL] [Abstract][Full Text] [Related]
5. Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.
Jones B; Zhan X; Mishin V; Slobod KS; Surman S; Russell CJ; Portner A; Hurwitz JL
Vaccine; 2009 Mar; 27(12):1848-57. PubMed ID: 19200447
[TBL] [Abstract][Full Text] [Related]
6. Vaccines for the Paramyxoviruses and Pneumoviruses: Successes, Candidates, and Hurdles.
Russell CJ; Simões EAF; Hurwitz JL
Viral Immunol; 2018 Mar; 31(2):133-141. PubMed ID: 29323621
[TBL] [Abstract][Full Text] [Related]
7. Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses.
Russell CJ; Hurwitz JL
Viruses; 2021 May; 13(6):. PubMed ID: 34072332
[TBL] [Abstract][Full Text] [Related]
8. A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge.
Russell CJ; Jones BG; Sealy RE; Surman SL; Mason JN; Hayden RT; Tripp RA; Takimoto T; Hurwitz JL
Virology; 2017 Sep; 509():60-66. PubMed ID: 28605636
[TBL] [Abstract][Full Text] [Related]
9. Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats.
Zhan X; Slobod KS; Jones BG; Sealy RE; Takimoto T; Boyd K; Surman S; Russell CJ; Portner A; Hurwitz JL
Int Immunol; 2015 May; 27(5):229-36. PubMed ID: 25477211
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus.
Takimoto T; Hurwitz JL; Zhan X; Krishnamurthy S; Prouser C; Brown B; Coleclough C; Boyd K; Scroggs RA; Portner A; Slobod KS
Viral Immunol; 2005; 18(2):255-66. PubMed ID: 16035938
[TBL] [Abstract][Full Text] [Related]
11. Relationships among dissemination of primary parainfluenza virus infection in the respiratory tract, mucosal and peripheral immune responses, and protection from reinfection: a noninvasive bioluminescence-imaging study.
Burke CW; Li M; Hurwitz JL; Vogel P; Russell CJ
J Virol; 2015 Apr; 89(7):3568-83. PubMed ID: 25589649
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children.
Adderson E; Branum K; Sealy RE; Jones BG; Surman SL; Penkert R; Freiden P; Slobod KS; Gaur AH; Hayden RT; Allison K; Howlett N; Utech J; Allay J; Knight J; Sleep S; Meagher MM; Russell CJ; Portner A; Hurwitz JL
Clin Vaccine Immunol; 2015 Mar; 22(3):298-303. PubMed ID: 25552633
[TBL] [Abstract][Full Text] [Related]
13. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults.
Scaggs Huang F; Bernstein DI; Slobod KS; Portner A; Takimoto T; Russell CJ; Meagher M; Jones BG; Sealy RE; Coleclough C; Branum K; Dickey M; Buschle K; McNeal M; Makowski M; Nakamura A; Hurwitz JL
Hum Vaccin Immunother; 2021 Feb; 17(2):554-559. PubMed ID: 32750273
[TBL] [Abstract][Full Text] [Related]
15. Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.
Jones BG; Sealy RE; Rudraraju R; Traina-Dorge VL; Finneyfrock B; Cook A; Takimoto T; Portner A; Hurwitz JL
Vaccine; 2012 Jan; 30(5):959-68. PubMed ID: 22119594
[TBL] [Abstract][Full Text] [Related]
16. Recent developments with live-attenuated recombinant paramyxovirus vaccines.
Le Bayon JC; Lina B; Rosa-Calatrava M; Boivin G
Rev Med Virol; 2013 Jan; 23(1):15-34. PubMed ID: 22570186
[TBL] [Abstract][Full Text] [Related]
17. Current developments and prospects on human metapneumovirus vaccines.
Márquez-Escobar VA
Expert Rev Vaccines; 2017 May; 16(5):419-431. PubMed ID: 28116910
[TBL] [Abstract][Full Text] [Related]
18. Recent vaccine development for human metapneumovirus.
Ren J; Phan T; Bao X
J Gen Virol; 2015 Jul; 96(Pt 7):1515-20. PubMed ID: 25667325
[TBL] [Abstract][Full Text] [Related]
19. Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase.
Zhang Y; Wei Y; Zhang X; Cai H; Niewiesk S; Li J
J Virol; 2014 Oct; 88(19):11411-29. PubMed ID: 25056882
[TBL] [Abstract][Full Text] [Related]
20. Live viral vaccines for respiratory and enteric tract diseases.
Chanock RM; Murphy BR; Collins PL; Coelingh KV; Olmsted RA; Snyder MH; Spriggs MK; Prince GA; Moss B; Flores J
Vaccine; 1988 Apr; 6(2):129-33. PubMed ID: 2838984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
